YB-1 activities in oncogenesis: Transcription and translation

Current Cancer Therapy Reviews

Volumn 2, Issue 1, 2006, Pages 31-39

  Bader, Andreas G ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

DbpB; EF IA; mRNP; NSEP 1; p50; Y box

Indexed keywords

DNA BINDING PROTEIN; OLIGONUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; RNA BINDING PROTEIN; Y BOX BINDING PROTEIN 1;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CARCINOGENESIS; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CORRELATION ANALYSIS; CYTOPLASM; DNA SEQUENCE; GENETIC TRANSCRIPTION AND TRANSLATION; HUMAN; JOINT CANCER; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; REVIEW; SEQUENCE HOMOLOGY; THYROID TUMOR;

EID: 33746159911     PISSN: 15733947     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339406775471786     Document Type: Review

References (110)

1. Evdokimova VM Ovchinnikov LP. Translational regulation by Y - box transcription factor: involvement of the major mRNA-associated protein, p50. Int J Biochem Cell Biol 1999; 31: 139-49.
2. Wolffe AP. Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. Bioessays 1994; 16: 245-51.
3. Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 2003; 25: 691-8.
4. Tekur S, Pawlak A, Guellaen G, Hecht NB. Contrin the human homologue of a germ-cell Y-box-binding protein: cloning, expression, and chromosomal localization. J Androl 1999; 20: 135-44.
5. Tafuri SR, Wolffe AP. Xenopus Y-box transcription factors: molecular cloning, functional analysis and developmental regulation. Proc Natl Acad Sci USA 1990; 87: 9028-32.
6. Yang J, Medvedev S, Yu J, et al. Absence of the DNA-/RNA-binding protein MSY2 results in male and female infertility. Proc Natl Acad Sci USA 2005; 102: 5755-60.
7. Grant CE, Deeley RG. Cloning and characterization of chicken YB-1: regulation of expression in the liver. Mol Cell Biol 1993; 13: 4186-96.
8. Ito K, Tsutsumi K, Kuzumaki T, Gomez PF, Otsu K, Ishikawa K. A novel growth-inducible gene that encodes a protein with a conserved cold-shock domain. Nucleic Acids Res 1994; 22: 2036-41.
9. Sabath DE, Podolin PL, Comber PG, Prystowsky MB. cDNA cloning and characterization of interleukin 2-induced genes in a cloned T helper lymphocyte. J Biol Chem 1990; 265: 12671-8.
10. Spitkovsky DD, Royer-Pokora B, Delius H, et al. Tissue restricted expression and chromosomal localization of the YB-1 gene encoding a 42 kD nuclear CCAAT binding protein. Nucleic Acids Res 1992; 20: 797-803.
11. Tafuri SR, Familari M, Wolffe AP. A mouse Y box protein, MSY1, is associated with paternal mRNA in spermatocytes. J Biol Chem 1993; 268: 12213-20.
12. Lu ZH, Books JT, Ley TJ. YB-1 is important for late-stage embryonic development; optimal cellular stress responses, and the prevention of premature senescence. Mol Cell Biol 2005; 25: 4625-37.
13. Ozer J, Faber M, Chalkley R, Sealy L. Isolation and characterization of a cDNA clone for the CCAAT transcription factor EFIA reveals a novel structural motif. J Biol Chem 1990; 265: 22143-52.
14. Bader AG, Vogt PK. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation. Mol Cell Biol 2005; 25: 2095-106.
15. Evdokimova V, Ruzanov P, Imataka H, et al. The major mRNA-associated protein YB-1 is a potent 5' cap-dependent mRNA stabilizer. Embo J 2001; 20: 5491-502.
16. Kloks CP, Spronk CA, Lasonder E, et al. The solution structure and DNA-binding properties of the cold-shock domain of the human Y-box protein YB-1. J Mol Biol 2002; 316: 317-26.
17. Kolluri R, Torrey TA, Kinniburgh AJ. A CT promoter element binding protein: definition of a double-strand and a novel single-strand DNA binding motif. Nucleic Acids Res 1992; 20:111-6.
18. Tafuri SP, Wolffe AP. DNA binding, multimerization, and transcription stimulation by the Xenopus Y box proteins in vitro. New Biol 1992; 4: 349-59.
19. Jones PG, VanBogelen RA, Neidhardt FC. Induction of proteins in response to low temperature in Escherichia coli. J Bacteriol 1987; 169: 2092-5.
20. Jiang W, Jones P, Inouye M. Chloramphenicol induces the transcription of the major cold shock gene of Escherichia coli, cspA. J Bacteriol 1993; 175: 5824-8.
21. Jones PG, Krah R, Tafuri SR, Wolffe AP. DNA gymse, CS7.4, and the cold shock response in Escherichia coli. J Bacteriol 1992; 174: 5798-802.
22. Jiang W, Hou Y, Inouye M. CspA, the major cold-shock protein of Escherichia coli, is an RNA chaperone. J Biol Chem 1997; 272: 196-202.
23. Jones PG, Inouye M. The cold-shock response - a hot topic. Mol Microbiol 1994; 11: 811-8.
24. Burd CG, Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins. Science 1994; 265: 615-21.
25. Bouvet P, Matsumoto K, Wolffe AP. Sequence-specific RNA recognition by the Xenopus Y-box proteins. An essential role for the cold shock domain. J Biol Chem 1995; 270: 28297-303.
26. Schroder K, Graumann P, Schnuchel A, Holak TA, Marahiel MA. Mutational analysis of the putative nucleic acid-binding surface of the cold-shock domain, CspB, revealed an essential role of aromatic and basic residues in binding of single-stranded DNA containing the Y-box motif. Mol Microbiol 1995; 16: 699-708.
27. Wang N, Yamanaka K, Inouye M. Acquisition of double-stranded DNA-binding ability in a hybrid protein between Escherichia coli CspA and the cold shock domain of human YB-1. Mol Microbiol 2000; 38: 526-34.
28. Warrant RW, Kim SH. alpha-Hehx-double helix interaction shown in the structure of a protamine-transfer RNA complex and a nucleoprotamine model. Nature 1978; 271: 130-5.
29. Izumi H, Imamura T, Nagatani G, et al. Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'- ->5' exonuclease activity. Nucleic Acids Res 2001; 29: 1200-7.
30. Gaudreault I, Guay D, Lebel M. YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins. Nucleic Acids Res 2004; 32: 316-27.
31. Didier DK, Schiffenbauer J, Woulfe SL, Zacheis M, Schwartz BD. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci USA 1988; 85: 7322-6.
32. MacDonald GH, Itoh-Lindstrom Y, Ting JP. The transcriptional regulatory protein, YB-1, promotes single-stranded regions in the DRA promoter. J Biol Chem 1995; 270: 3527-33.
33. Stenina OI, Shaneyfelt KM, DiCorleto PE. Thrombin induces the release of the Y-box protein dbpB; from mRNA: a mechanism of transcriptional activation. Proc Natl Acad Sci USA 2001; 98: 7277-82.
34. Hasegawa SL, Doetsch PW, Hamilton KK, et al. DNA binding properties of YB-1 and dbpA: binding to double-stranded, single-stranded, and abasic site containing DNAs. Nucleic Acids Res 1991; 19:4915-20.
35. Horwitz EM, Maloney KA, Ley TJ. A human protein containing a "cold shock" domain binds specifically to H-DNA upstream from the human gamma-globin genes. J Biol Chem 1994; 269: 14130-9.
36. Lenz J, Okenquist SA, LoSardo JE, Hamilton KK, Doetsch PW. Identification of a mammaalian nuclear factor and human cDNA-encoded proteins that recognize DNA containing apurinic sites. Proc Natl Acad Sci USA 1990; 87: 3396-400.
37. Ise T, Nagatani G, Imamura T, et al. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res 1999; 59: 342-6.
38. Norman JT, Lindahl GE, Shakib K, En-Nia A, Yilmaz E, Mertens PR. The Y-box. binding protein YB-1 suppresses collagen alpha 1 (I) gene transcription Wa an evolutionarily conserved regulatory element in the proximal promoter. J Biol Chem 2001; 276: 29880-90.
39. En-Nia A, Yilmaz E, Klinge U, Lovett DH, Stefanidis I, Mertens PR. Transcription factor YB-1 mediates DNA polymeme alpha gene expression. J Biol Chem 2005; 280: 7702-11.
40. Zasedateleva OA, Krylov AS, Prokopenko DV, Skabkin MA, Ovchinnikov LP, Kolchinsky A, Mirzabekov AD. Specificity of mammalian Y-box binding protein p50 in interaction with ss and ds DNA analyzed with generic ohgonucleotide microchip. J Mol Biol 2002; 324:73-87.
41. Fukada T, Tonks NK. Identification of YB-1 as a regulator of PTP1B expression: implications for regulation of insulin and cytoldne signaling. Embo J 2003; 22: 479-93.
42. Mertens PR, Harendza S, Pollock AS, Lovett DH. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J Biol Chem 1997; 272: 22905-12.
43. Ohga T, Uchiumi T, Makino Y, et al. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J Biol Chem 1998; 273: 5997-6000.
44. Scarpati EM, DiCorleto PE. Identification of a thrombin response element in the human platelet-derived growth factor B-chain (c-sis) promoter. J Biol Chem 1996; 271: 3025-32.
45. Stenina OI, Poptic EJ, DiCorleto PE. Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells. J Clin Invest 2000; 106: 579-87.
46. Jurchott K, Bergmann S, Stein U, er al. YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression. J Biol Chem 2003; 278: 27988-96.
47. Ting JP, Painter A, Zeleznik-Le NJ, et al. YB-1 DNA-binding protein represses interferon gamma activation of class II major histocompatibility complex genes. J Exp Med 1994; 179: 1605-11.
48. Lasham A, Lindridge E, Rudert F, Onrust R, Watson J. Regulation of the human fas promoter by YB-1, Puralpha and AP-1 transcription factors. Gene 2000; 252: 1-13.
49. Uchiumi T, Kohno K, Tanimura, H, et al. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differ 1993; 4: 147-57.
50. Henglein B, Chenivesse X, Wang J, Eick D, Brechot C. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Nad Acad Sci USA 1994; 91: 5490-4.
51. Katula KS, Wright KL, Paul H, et al. Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements. Cell Growth Differ 1997; 8: 811-20.
52. Yang J, Medvedev S, Reddi PP, Schultz RM, Hecht NB. The DNA/RNA-binding protein MSY2 marks specific transcripts for cytoplasmic storage in mouse male germ cells. Proc Natl Acad Sci USA 2005; 102:1513-8.
53. Hieronymus H, Silver PA. A systems view of mRNP biology. Genes Dev 2004; 18: 2845-60.
54. Spirin AS. The second Sir Hans Krebs Lecture. Informosomes. Eur J Biochem 1969; 10: 20-35.
55. Barrieux A, Ingraham HA, Nystul S, Rosenfeld MG. Characterization of the association of specific proteins with messenger ribonucleic acid. Biochemistry 1976; 15: 3523-8.
56. Blobel G. Protein tightly bound to globin mRNA. Biochem Biophys Res Commun 1972; 47: 88-95.
57. Bryan RN, Hayashi M. Two proteins are bound to most species of polysomal mRNA. Nat New Biol 1973; 244: 271-4.
58. Blobel G. A protein of molecular weight 78,000 bound to the polyadenylate region of eukaryotic messenger RNAs. Proc Natl Acad Sci USA 1973; 70: 924-8.
59. van Venrooij WJ, van Eekelen CA, Jansen RT, Princen JM. Specific poly-A-binding protein of 76,000 molecular weight in polyribosomes is not present on poly A of free cytoplasmic mRNP. Nature 1977; 270: 189-91.
60. Evdokimova VM, Wei CL, Sitikov AS, et al. The major protein of messenger ribonucleoprotein particles in somatic cells is a member of the Y-box binding transcription factor family. J Biol Chem 1995; 270: 3186-92.
61. Minich WB, Maidebura IP, Ovchinnikov LP. Purification and characterization of the major 50-kDa repressor protein from cytoplasmic mRNP of rabbit reticulocytes. Eur J Biochem 1993; 212: 633-8.
62. Davydova EK, Evdokimova VM, Ovchinnikov LP, Hershey JW. Overexpression in COS cells of p50, the major core protein associated with mRNA, results in translation inhibition. Nucleic Acids Res 1997; 25: 2911-6.
63. Tafuri SR, Wolffe AP. Selective recruitment of masked maternal mRNA from messenger ribonucleoprotein particles containing FRGY2 (mRNP4). J Biol Chem 1993; 268: 24255-61.
64. Pisarev AV, Skabkin MA, Thomas AA, Merrick WC, Ovchinnikov LP, Shatsky IN. Positive and negative effects of the major mammalian messenger ribonucleoprotein p50 on binding of 40 S ribosomal subunits to the initiation codon of beta-globin mRNA. J Biol Chem 2002; 277: 15445-51.
65. Minich WB, Ovchinnikov LP. Role of cytoplasmic mRNP proteins in translation. Biochimie 1992; 74: 477-83.
66. Nekrasov MP, Ivshina MP, Chernov KG, et al. The mRNA-binding protein YB-1 (p50) prevents association of the eukaryotic initiation factor eIF4G with mRNA and inhibits protein synthesis at the initiation stage. J Biol Chem 2003; 278: 13936-43.
67. Bouvet P, Wolffe AP. A role for transcription and FRGY2 in masking maternal mRNA within Xenopus oocytes. Cell 1994; 77: 931-41.
68. Soop T, Nashchekin D, Zhao J, et al. A p50-like Y-box protein with a putative translational role becomes associated with pre-mRNA concomitant with transcription. J Cell Sci 2003; 116: 1493-503.
69. Rarjan M, Tafuri SR, Wolffe AP. Masking mRNA from translation in somatic cells. Genes Dev 1993; 7: 1725-36.
70. Matsumoto K, Meric F, Wolffe AP. Translational repression dependent on the interaction of the Xenopus Y-box protein FRGY2 with mRNA. Role of the cold shock domain, tail domain, and selective RNA sequence recognition. J Biol Chem 1996; 271: 22706-12.
71. Skabkina OV, Skabkin MA, Popova NV, Lyabin DN, Penalva LO, Ovchinnikov LP. Poly(A)-binding protein positively affects YB-1 mRNA translation through specific interaction with YB-1 mRNA. J Biol Chem 2003; 278: 18191-8.
72. Skabkina OV, Lyabin DN, Skabkin MA, Ovchinnikov LP. YB-1 autoregulates translation of its own mRNA at or prior to the step of 40S ribosomal subunit joining. Mol Cell Biol 2005; 25: 3317-23.
73. Chen CY, Gherzi R, Andersen JS, et al. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 2000; 14: 1236-48.
74. Koike K, Uchiumi T, Ohga T, et al. Nuclear translocation of the Y-box binding protein by ultraviolet irradiation. FEBS Lett 1997; 417: 390-4.
75. Raffetseder U, Frye B, Rauen T, et al. Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J Biol Chem 2003; 278: 18241-8.
76. Holm PS, Lage H, Bergmann S, et al. Multidrug-Tesistant Cancer Cells Facilitate E1 -independent Adenoviral Replication: Impact for Cancer Gone Therapy. Cancer Res 2004; 64: 322-8.
77. Zhang YF, Homer C, Edwards SJ, et al. Nuclear localization of Y-box factor YB1 requires wild-type p53. Oncogene 2003; 22: 2782-94.
78. Kick D, Barrett P, Cummings A, Sommerville J. Phosphorylation of a 60 kDa polypeptide from Xenopus oocytes blocks messenger RNA translation. Nucleic Acids Res 1987; 15: 4099-109.
79. Sutherland BW, Kucab J, Wu J, et al. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 2005; 24: 4281-92.
80. Uchiumi T, Kohno K, Tanimura H, et al. Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter. FEBS Lett 1993; 326:11-6.
81. Bader AG, Felts KA, Jiang N, Chang HW, Vogt PK. Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol. 3-kinase pathway. Proc Natl Acad Sci USA 2003; 100: 12384-9.
82. Chernukhin IV, Shamsuddin S, Robinson AF, et al. Physical and functional interaction between two pluripotent proteins, the Y-box DNA/RNA-binding factor, YB-1, and the multivalent zinc finger factor, CTCF. J Biol Chem 2000; 275: 29915-21.
83. Higashi K, Inagaki Y, Fujimori K, Nakao A, Kaneko H, Nakatsuka I. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. J Biol Chem 2003; 278: 43470-9.
84. Mertens PR, Alfonso-Jaume MA, Steinmann K, Lovett DH. A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J Biol Chem 1998; 273: 32957-65.
85. Ohba H, Chiyoda T, Endo E, et al. Sox21 is a repressor of neuronal differentiation and is antagonized by YB-1. Neurosci Lett 2004; 358: 157-60.
86. Okamoto T, Izumi H, Imamura T, et al. Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression. Oncogene 2000; 19: 6194-202.
87. Chansky HA, Hu M, Hickstein DD, Yang L. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res 2001; 61: 3586-90.
88. Ceman S, Nelson R, Warren ST. Identification of mouse YB1/p5O as a component of the FMRP-associated mRNP particle. Biochem Biophys Res Commun 2000; 279: 904-8.
89. Matsumoto K, Tanaka KJ, Tsujimoto M. An acidic protein, YBAP1, mediates the release of YB-1 from mRNA and relieves the translational repression activity of YB-1. Mol Cell Biol 2005; 25: 1779-92.
90. Ruzanov PV, Evdokimova VM, Korneeva NL, Hershey JW, Ovchinnikov LP. Interaction of the universal mRNA-binding protein, p50, with actin: a possible link between mRNA and microfilaments. J Cell Sci 1999; 112 (Pt 20): 3487-96.
91. Gai XX, Lipson KE, Prystowsky MB. Unusual DNA binding characteristics of an in vitro translation product of the CCAAT binding protein mYB-1. Nucleic Acids Res 1992; 20: 601-6.
92. Sakura H, Maekawa T, Imamoto F, Yasuda K, Lshii S. Two human genes isolated by a novel method encode DNA-binding proteins containing a common region of homology. Gene 1988; 73: 499-507.
93. Bergmann S, Royer-Pokora B, Fietze E, et al. YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res 2005; 65: 4078-87.
94. Bargou RC, Jurchott K, Wagener C, et al. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 1997; 3: 447-50.
95. Janz M, Harbeck N, Dettmar P, et al. Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Int J Cancer 2002; 97: 278-82.
96. Oda Y, Ohishi Y, Saito T, et al. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma. J Pathol 2003; 199: 251-8.
97. Oda Y, Sakamoto A, Shinohara N, et al. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma. Clin Cancer Res 1998; 4: 2273-7.
98. Saji H, Toi M, Saji S, Koike M, Kohno K, Kuwano M. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma. Cancer Lett 2003; 190: 191-7.
99. Shibahara K, Sugio K, Osaki T, et al. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res 2001; 7: 3151-5.
100. Yahata H, Kobayashi H, Kamura, T, et al. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer. J Cancer Res Clin Oncol 2002; 128: 621-6.
101. Yoshimatsu T, Uramoto H, Oyama T, et al. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer. Anticancer Res 2005; 25: 3437-43.
102. Shibao K, Takano H, Nakayama Y, et al. Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas. Int J Cancer 1999; 83: 732-7.
103. Aoki M, Blazek E, Vogt PK. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc Natl Acad Sci USA 2001; 98: 136-41.
104. Bader AG, Vogt PK. An essential role for protein synthesis in oncogenic cellular transformation. Oncogene 2004; 23: 3145-50.
105. Fingar DC, Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004; 23: 3151-71.
106. Vassilev LT, Vu BT, Graves B, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004; 303: 844-8.
107. Tsutsumi K, Ito K, Yabuki T, Ishikawa. K. A1F-B, a novel CCAAT-binding transcription activator that interacts with the aldolase B promoter. FEBS Lett 1993; 321: 51-4.
108. Kolluri R, Kinniburgh AJ. Full length cDNA sequence encoding a nuclease-sensitive element DNA binding protein. Nucleic Acids Res 1991; 19: 4771.
109. Yan C, Tamm I. Molecular cloning and characterization of interferon alpha/beta response element binding factors of the murine (2'-5')oligoadenylate synthetase ME-12 gene. Proc Natl Acad Sci USA 1991; 88: 144-8.
110. Ito Y, Yoshida H, Shibahara K, et al. Y-box binding protein expression in thyroid neoplasms: its linkage with anaplastic transformation. Pathol Int 2003; 53: 429-33.